ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Clinical trials for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to cut deaths in severe pneumonia patients
Disease control TerminatedThis study was designed to test whether adding two experimental agents (nogapendekin alfa inbakicept and iNKT cells) to standard care could lower the risk of death within 28 days in critically ill adults with severe community-acquired pneumonia, with or without sepsis or acute re…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: PHASE3 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New antibody aims to help lungs heal faster in severe breathing emergencies
Disease control OngoingThis study tests a single dose of an experimental antibody called ALT-100 in 15 adults hospitalized with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. The main goal is to check safety and side effects, while also seeing if it re…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
AI vs. doctors: who makes better choices for sepsis and lung failure?
Knowledge-focused ENROLLING_BY_INVITATIONThis study asks critical care doctors and advanced practice providers to review patient cases of sepsis and ARDS. They will evaluate treatment recommendations and guess whether each came from a human doctor or an artificial intelligence system. The goal is to see if AI can produc…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC